Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.

Goldie SJ, O'Shea M, Diaz M, Kim SY.

Reprod Health Matters. 2008 Nov;16(32):86-96. doi: 10.1016/S0968-8080(08)32409-4.

2.
3.

Human papillomavirus vaccine policy and delivery in Latin America and the Caribbean.

Andrus JK, Lewis MJ, Goldie SJ, García PJ, Winkler JL, Ruiz-Matus C, de Quadros CA.

Vaccine. 2008 Aug 19;26 Suppl 11:L80-7. doi: 10.1016/j.vaccine.2008.05.040. Review.

PMID:
18945405
4.

Human papillomavirus vaccine: a paradigm shift for pediatricians.

Jenson HB.

Curr Opin Pediatr. 2009 Feb;21(1):112-21. doi: 10.1097/MOP.0b013e3283207f93. Review.

PMID:
19242247
5.

Recommendations for cervical cancer prevention in Latin America and the Caribbean.

Muñoz N, Franco EL, Herrero R, Andrus JK, de Quadros C, Goldie SJ, Bosch FX.

Vaccine. 2008 Aug 19;26 Suppl 11:L96-L107. doi: 10.1016/j.vaccine.2008.05.062. Review.

PMID:
18945407
6.

[Efficiency of human papillomavirus vaccination--estimates based on Dutch cost effectiveness analyses].

Westra TA, Daemen T, Postma MJ, Wilschut JC.

Ned Tijdschr Geneeskd. 2009;153:A356. Review. Dutch.

PMID:
19930733
7.

Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006-January 2008.

Koulova A, Tsui J, Irwin K, Van Damme P, Biellik R, Aguado MT.

Vaccine. 2008 Dec 2;26(51):6529-41. doi: 10.1016/j.vaccine.2008.08.067. Review.

PMID:
18805453
8.

Worldwide impact of the human papillomavirus vaccine.

Hakim AA, Dinh TA.

Curr Treat Options Oncol. 2009 Apr;10(1-2):44-53. doi: 10.1007/s11864-009-0094-4. Epub 2009 Apr 23. Review.

PMID:
19387841
9.

Effectiveness and cost effectiveness of human papillomavirus vaccine: a systematic review.

Marra F, Cloutier K, Oteng B, Marra C, Ogilvie G.

Pharmacoeconomics. 2009;27(2):127-47. doi: 10.2165/00019053-200927020-00004. Review. Erratum in: Pharmacoeconomics. 2009;27(4):354.

PMID:
19254046
10.

[Vaccines against human papillomavirus (HPV); between registration and implementation].

van Rossum TG, de Melker HE, Houweling H, Voordouw AC, Meijer CJ, Helmerhorst TJ, Kretzschmar M, Berkhof J, van der Noordaa J.

Ned Tijdschr Geneeskd. 2008 Apr 26;152(17):987-92. Review. Dutch.

PMID:
18549172
11.

Economic evaluation of human papillomavirus vaccination in developed countries.

Brisson M, Van de Velde N, Boily MC.

Public Health Genomics. 2009;12(5-6):343-51. doi: 10.1159/000214924. Epub 2009 Aug 11. Review.

PMID:
19684446
12.
13.

Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean.

Franco EL, Tsu V, Herrero R, Lazcano-Ponce E, Hildesheim A, Muñoz N, Murillo R, Sánchez GI, Andrus JK.

Vaccine. 2008 Aug 19;26 Suppl 11:L88-95. doi: 10.1016/j.vaccine.2008.05.026. Review.

PMID:
18945406
14.

Integrating human papillomavirus vaccination in cervical cancer control programmes.

Franco EL, Coutlée F, Ferenczy A.

Public Health Genomics. 2009;12(5-6):352-61. doi: 10.1159/000214925. Epub 2009 Aug 11. Review.

PMID:
19684447
15.

The quadrivalent human papillomavirus vaccine: potential factors in effectiveness.

Zonfrillo NJ, Hackley B.

J Midwifery Womens Health. 2008 May-Jun;53(3):188-94. doi: 10.1016/j.jmwh.2007.12.015. Review.

PMID:
18455092
16.

Implementation of human papillomavirus immunization in the developing world.

Kane MA, Serrano B, de Sanjosé S, Wittet S.

Vaccine. 2012 Nov 20;30 Suppl 5:F192-200. doi: 10.1016/j.vaccine.2012.06.075. Review.

PMID:
23199963
17.

Human papillomavirus infection and the primary and secondary prevention of cervical cancer.

Lowy DR, Solomon D, Hildesheim A, Schiller JT, Schiffman M.

Cancer. 2008 Oct 1;113(7 Suppl):1980-93. doi: 10.1002/cncr.23704. Review.

18.

Vaccination against HPV: indications for women and the impact on the cervical screening programme.

Heideman DA, Snijders PJ, Berkhof J, Verheijen RH, Helmerhorst TJ, Meijer CJ.

BJOG. 2008 Jul;115(8):938-46. doi: 10.1111/j.1471-0528.2008.01779.x. Review.

19.

Human papilloma virus vaccination: should it be mandatory?

Prasai S.

JNMA J Nepal Med Assoc. 2008 Jul-Sep;47(171):167-71. Review.

PMID:
19079386
20.

Human papillomavirus vaccine: recommendations, issues and controversies.

Fisher R, Darrow DH, Tranter M, Williams JV.

Curr Opin Pediatr. 2008 Aug;20(4):441-5. doi: 10.1097/MOP.0b013e328305e298. Review.

PMID:
18622201

Supplemental Content

Support Center